Abstract
Many congenital syndromes are diagnosed with the aid of cutaneous findings. Certain medical conditions are detected early based on the appearance of premature, numerous, or abnormal skin lesions. The association of melanocytic nevi with specific syndromes is prominent with certain conditions and less consistent with others. Melanocytic nevi are fairly prevalent in the general population and often exhibit familial clustering; therefore, close attention must be paid to all associated findings in order to recognize the pattern of various syndromes and facilitate counseling and timely intervention.
This chapter describes syndromes associated with melanocytic nevi.
Keywords
- Malignant Peripheral Nerve Sheath Tumor
- Xeroderma Pigmentosum
- Melanocytic Nevus
- Carney Complex
- Sertoli Cell Tumor
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Carney JA (1995) The Carney complex (myxomas, spotty pigmentation, endocrine overactivity and schwannomas). Dermatol Clin 13:19–25
Bett BJ (2006) Large or multiple congenital melanocytic nevi: occurrence of neurocutaneous melanocytosis in 1008 persons. J Am Acad Dermatol 54:767–777
Bale SJ, Digiovanna JJ (2001) Cancer-associated genodermatosis and familial cancer syndromes with cutaneous manifestations. Clin Dermatol 19:284–289
Ball NJ, Kho GT (2005) Melanocytic nevi are associated with neurofibromas in neurofibromatosis, type I, but not sporadic neurofibromas. A study of 226 cases. J Cutan Pathol 32:523–532
Brasfield RD, Das Gupta TK (1972) Von Recklinghausen's disease: a clinicopathological study. Ann Surg 175:86–104
Kadonaga N, Frieden J (1991) Neurocutaneous melanosis. Definition and review of the literature. J Am Acad Dermatol 24:747–755
Moriwaki SI, Kraemer KH (2001) Xeroderma pigmentosum: bridging a gap between clinic and laboratory. Photodermatol Photoimmunol Photomed 17:47–54
Perera GK, Atherton D (2006) The value of MRI in a patient with occult spinal dysraphism. Pediatr Dermatol 23:24–26
Theos A, Korf B (2006) Pathophysiology of neurofibromatosis type 1. Ann Intern Med 144:842–849
Wander JV, Das Gupta TK (1977) Neurofibromatosis. Curr Prob Surg 14:26–73
Zahorcsek Z, Schneider I (1996) Generalized lentiginosis manifesting through three generations. Int J Dermatol 35:357–359
Crowe FW, Schull WJ, Neel JV (1956) A clinical, pathological and genetic study of multiple neurofibromatosis. Charles C. Thomas, Springfield, Ill., p. 181
Atherton DJ, Pitcher DW, Wels RS et al. (1980) A syndrome of various cutaneous pigmented lesions, myxoid neurofibromatoma and atrial myxoma: the NAME syndrome. Br J Dermatol 103:421–429
Rhodes AR, Silverman RA, Harrist TJ et al. (1984) Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple nlue nevi: the LAMB syndrome. J Am Acad Dermatol 10:72–82
Carney JA, Gordon, H, Carpenter PC et al. (1985) The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine 64:270–283
Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250
Bootsma D, Kraemer KH, Cleaver JE et al. Nucleotide excision repair syndromes: xeroderma pigmentosum, Cocakyne syndrome and trichothiodystrophy.
Brophy JD, Sutton LN, Zimmerman RA et al. (1989) Magnetic resonance imaging of lipomyelomeningocele. Neurosurgery 25: 336–340
Gorlin RJ, Cohen MN, Levin LS (1990) Syndromes of the head and neck, 3rd edn. New York: Oxford University Press
Byrd SE, Darling CF, Tomita T et al. (1991) MR imaging of symptomatic neurocutaneous melanosis in children. Pediatr Radiol 27:39–44
Cannon-Albright LA, Goldgar DE, Meyer LJ et al. (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13–p22. Science 258:1148–1152
Kadonaga N, Barkovich JA, Edwards MSB, Frieden IJ (1992) Neurocutaneous melanosis in association with the Dandy–Walker complex. Pediatr Dermatol 9:37–43
Tucker MA, Fraser MC, Goldstein AM, et al. (1993) Risk of melanoma and other cancers in melanomaprone families. J Invest Dermatol 100 (Suppl):350s–355s
Ball NF, John JJ, Morelli JG et al. (1994) Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol 102:285s
Davis DA, Cohen PR, George RE. (1994) Cutaneous stigmata of occult spinal dysraphism. J Am Acad Dermatol 31:892–896
Goldstein AM, Fraser MC, Clark WHJ, Tucker MA (1994) Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi. J Natl Cancer Inst 86:1385–1390
Hussussian CJ, Struewing JP, Goldstein AM et al. (1994) Germline p16 mutations in familial melanoma. Nat Genet 8:15–21
Goldstein AM, Fraser MC, Struewing JP et al. (1995) Increased risk of pancreatic cancer in melanomaprone kindreds with p16 mutations. N Engl J Med 333:970–974
Chaloupka JC, Wolf RJ, Varma PK (1996) Neurocutaneous melanosis with the Dandy–Walker malformation: a possible rare pathoetiologic association. Neuroroadiology 38:486–489
De David M, Orlow SJ, Provost N, et al. (1996) Neurocutaneous melanosis: clinical features of large congenital nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol 35:529–538
Casey M, Mah C, Merliss AD et al. (1998) Identification of a novel genetic loci for familial cardiac myxomas and Carney complex. Circulation 98:2560–2566
Okulicz JF, Schwartz RA, Jozwiak S (2001) Lentigo. Cutis 67:367–370
Abdelmalek NF, Gerber TL, Menter A (2002) Cardiocutaneous syndromes and associations. J Am Acad Dermatol 46:161–183
Evans DG, Baser ME, McGaughran J et al. (2002) Malignant peripheral nerve root sheath tumours in neurofibromatosis 1. J Med Genet 39:311–314
Mena-Cedillos CA, Valencia-Herrera AM, Arroyo-Pineda AI et al. (2002) Neurocutaneous melanosis in association with the Dandy–Walker complex, complicated by melanoma. Pediatr Dermatol 19:237–242
Itin PH, Burgdorf WH, Happle R et al. (2003) Genodermatosis. In: Schachner LA, Hansen RC (2003) Pediatric dermatology. Mosby, Elsevier Limited, Philadelphia
Marghoob A, Borrego J, Halpern A (2003) Congential melanocytic nevi: treatment modalities and management options. Semin Cut Med Surg 22:21–32
Pollock PM, Harper UL, Hansen KS et al. (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19
Roco F di, Sabatino G, Koutzoglou M (2004) Neurocutaneous melanosis. Childs Nerv Syst 20:23–28
Guggisberg D, Hadj-Rabia S, Viney C et al. (2004) Skin markers of occult spinal dysraphism in children: a review of 54 cases. Arch Dermatol 140:1109–1115
Hale EK, Stein J, Ben-Porat L et al. (2005) Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi: results from the NYU-LCMN registry. Br J Dermatol 152:512–517
Robinson AJ, Russell S, Rimmer S (2005) The value of ultrasonic examination of the lumbar spine in infants with specific reference to cutaneous markers of occult spinal dysraphism. Clin Radiol 60:72–77
Somoano B, Niendorf KB, Tsao H (2005) Hereditary cancer syndromes of the skin. Clin Dermatol 23:85–106
Marghoob AA, Dusza S, Oliveria S (2004) Number of Satellite Nevi as a Correlate for Neurocutaneous Melanocytic Nevi. Arch Dermatol 140:171-175.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2007). Syndromes Involving Melanocytic Lesions. In: Soyer, H., Argenziano, G., Hofmann-Wellenhof, R., Johr, R. (eds) Color Atlas of Melanocytic Lesions of the Skin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35106-1_25
Download citation
DOI: https://doi.org/10.1007/978-3-540-35106-1_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-35105-4
Online ISBN: 978-3-540-35106-1
eBook Packages: MedicineMedicine (R0)